SomaLogic wins NSF grant for proteomic device development
BOULDER — SomaLogic Inc., a Boulder-based bioscience firm, along with partners at the University of Chicago, University of California Los Angeles, University of California Santa Barbara and University of Washington, were recently awarded a $1 million grant from the National Science Foundation to develop devices that use quantum sensing methods for proteomic screening.
Proteomic screening is the process of detecting proteins in biological samples such as blood or urine.
“If successful, the new technology will be employed to more conveniently identify specific protein patterns that reflect an individual’s current health, future disease risk and the impact of behavioral or therapeutic interventions,” according to a SomaLogic news release.
SPONSORED CONTENT
Business Cares: March 2024
WomenGive, a program of United Way of Larimer County, was started in Larimer County in 2006 as an opportunity for women in our community to come together to help other women.
The grant funding is provided through NSF’s Convergence Accelerator program.
© 2020 BizWest Media LLC
BOULDER — SomaLogic Inc., a Boulder-based bioscience firm, along with partners at the University of Chicago, University of California Los Angeles, University of California Santa Barbara and University of Washington, were recently awarded a $1 million grant from the National Science Foundation to develop devices that use quantum sensing methods for proteomic screening.
Proteomic screening is the process of detecting proteins in biological samples such as blood or urine.
“If successful, the new technology will be employed to more conveniently identify specific protein patterns that reflect an individual’s current health, future disease risk and the impact…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!